SHARE
COPY LINK

EBOLA

UN head issues Ebola quarantine warning

UN chief Ban Ki-moon warned Monday against "unnecessarily" strict restrictions on health workers returning from treating Ebola patients, in an apparent reference to quarantines and visa bans by some Western nations.

UN head issues Ebola quarantine warning
UN Secretary General Ban Ki-moon. Photo: APA (Archiv/epa)

"There are some unnecessarily extra restrictions and discriminations against health workers. These people are … risking their own lives," Ban told a news conference in Vienna.

Without naming any country, Ban said that these "unnecessarily strong and strict restrictions" included "quarantine for health workers … not based on science and medical evidence".

"That is my honest and urgent opinion to the international community," he said, stressing however that people with Ebola symptoms "should be immediately treated and supported".

Experts say quarantining medical professionals who have shown no symptoms of the virus is counter-productive and could deter other workers from helping contain west Africa's Ebola crisis.

In a case which attracted international criticism, New Jersey Governor Chris Christie kept a nurse in an isolation tent for three days after she flew back from Sierra Leone.

Meanwhile Canada and Australia controversially announced last week that they were suspending visa applications from Ebola-hit west African nations.

Almost 5,000 people have been killed by Ebola, according to the World Health Organization, which has recorded more than 13,000 cases but admits the real number of could be could be much higher.

Ban was speaking at a UN conference of developing landlocked countries in the Austrian capital.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

EBOLA

Spanish researchers develop five-strain vaccine against lethal Ebola virus

Spanish researchers are working on a vaccine against all five strains of the killer Ebola virus in what would be a world first, Madrid's October 12 Hospital said Wednesday (July 11).

Spanish researchers develop five-strain vaccine against lethal Ebola virus
Ebola protects itself with proteins that act as a shield, and only exposes its vulnerable zones for short periods of time. Photo: AFP

A prototype vaccine developed by pharmaceutical group Merck is already in use, but acts only against the most virulent, “Zaire” strain.

Despite not having market approval, Merck's rVSV-ZEBOV was administered to people in the Democratic Republic of Congo in May, with UN approval, in a bid to contain an outbreak of the same virus that killed more than 11,300 in three West African countries from 2013 to 2015, sparking international panic.

For several months, a team from the October 12 Hospital has been working with researchers at two other hospitals in the capital to examine and learn from blood samples taken from three people cured of Ebola in Spain.

Lead researcher Rafael Delgado told reporters the difficulty lay in the fact that the virus protects itself with proteins that act as a shield, and only exposes its vulnerable zones for short periods of time.

That makes it tough for the body's immune system to fight the virus.

The three Spanish patients had produced “very effective” viral antibodies, though in a “small quantity” and only against the Zaire strain they were contaminated with.

Delgado, head of microbiology at the hospital, said researchers are aiming to reproduce these antibodies on a larger scale, and in a way that would make them efficient against all five virus strains.

US medical giant Johnson & Johnson is separately developing an experimental vaccine against two Ebola strains.

Delgado said researchers hope to get results from mouse experiments within a year.

The Ebola epidemic caused alarm in Spain in 2014 when a nursing assistant, Teresa Romero, became the first person infected outside Africa.

She caught the disease while tending to a Spanish missionary repatriated from Sierra Leone, who died in Spain in September that year.